241 related articles for article (PubMed ID: 23733874)
21. An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice.
Inoue M; Senju S; Hirata S; Irie A; Baba H; Nishimura Y
Immunol Lett; 2009 Sep; 126(1-2):67-72. PubMed ID: 19682495
[TBL] [Abstract][Full Text] [Related]
22. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862
[TBL] [Abstract][Full Text] [Related]
23. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
Richard V; Lairmore MD; Green PL; Feuer G; Erbe RS; Albrecht B; D'Souza C; Keller ET; Dai J; Rosol TJ
Am J Pathol; 2001 Jun; 158(6):2219-28. PubMed ID: 11395400
[TBL] [Abstract][Full Text] [Related]
24. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
25. Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
Kannagi M; Ohashi T; Harashima N; Hanabuchi S; Hasegawa A
Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062
[TBL] [Abstract][Full Text] [Related]
26. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
Furukawa Y; Kubota R; Tara M; Izumo S; Osame M
Blood; 2001 Feb; 97(4):987-93. PubMed ID: 11159527
[TBL] [Abstract][Full Text] [Related]
27. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL].
Tanaka Y; Kanda Y
Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144
[TBL] [Abstract][Full Text] [Related]
28. Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse model.
Mori F; Ishida T; Ito A; Sato F; Masaki A; Narita T; Suzuki S; Yamada T; Takino H; Ri M; Kusumoto S; Komatsu H; Hishizawa M; Imada K; Takaori-Kondo A; Niimi A; Ueda R; Inagaki H; Iida S
Eur J Haematol; 2014 Mar; 92(3):219-28. PubMed ID: 24188416
[TBL] [Abstract][Full Text] [Related]
29. Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia.
Kannagi M
Int J Hematol; 2007 Aug; 86(2):113-7. PubMed ID: 17875523
[TBL] [Abstract][Full Text] [Related]
30. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.
Ohashi T; Hanabuchi S; Kato H; Tateno H; Takemura F; Tsukahara T; Koya Y; Hasegawa A; Masuda T; Kannagi M
J Virol; 2000 Oct; 74(20):9610-6. PubMed ID: 11000233
[TBL] [Abstract][Full Text] [Related]
31. Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia.
Kawamura K; Tanaka Y; Nakasone H; Ishihara Y; Kako S; Kobayashi S; Tanaka Y; Ohmori T; Uchimaru K; Okamoto S; Mineno J; Shiku H; Nishimura S; Kanda Y
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1377-1385. PubMed ID: 32311478
[TBL] [Abstract][Full Text] [Related]
32. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
[TBL] [Abstract][Full Text] [Related]
33. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
[TBL] [Abstract][Full Text] [Related]
34. CD34+ cord blood DC-induced antitumor lymphoid cells have efficacy in a murine xenograft model of human ALL.
Cullup H; Hsu AK; Kassianos AJ; McDonald K; Radford KJ; Rice AM
J Immunother; 2011 May; 34(4):362-71. PubMed ID: 21499125
[TBL] [Abstract][Full Text] [Related]
35. Potential immunogenicity of adult T cell leukemia cells in vivo.
Kurihara K; Harashima N; Hanabuchi S; Masuda M; Utsunomiya A; Tanosaki R; Tomonaga M; Ohashi T; Hasegawa A; Masuda T; Okamura J; Tanaka Y; Kannagi M
Int J Cancer; 2005 Mar; 114(2):257-67. PubMed ID: 15551352
[TBL] [Abstract][Full Text] [Related]
36. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice.
Kawano N; Ishikawa F; Shimoda K; Yasukawa M; Nagafuji K; Miyamoto T; Baba E; Tanaka T; Yamasaki S; Gondo H; Otsuka T; Ohshima K; Shultz LD; Akashi K; Harada M
Leukemia; 2005 Aug; 19(8):1384-90. PubMed ID: 15959532
[TBL] [Abstract][Full Text] [Related]
37. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.
Miyazato P; Yasunaga J; Taniguchi Y; Koyanagi Y; Mitsuya H; Matsuoka M
J Virol; 2006 Nov; 80(21):10683-91. PubMed ID: 16943297
[TBL] [Abstract][Full Text] [Related]
38. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
Zhang Z; Zhang M; Goldman CK; Ravetch JV; Waldmann TA
Cancer Res; 2003 Oct; 63(19):6453-7. PubMed ID: 14559836
[TBL] [Abstract][Full Text] [Related]
39. Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines.
Ohsugi T; Kumasaka T; Okada S; Ishida T; Yamaguchi K; Horie R; Watanabe T; Umezawa K
Cancer Lett; 2007 Nov; 257(2):206-15. PubMed ID: 17764832
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
Sugata K; Yasunaga J; Mitobe Y; Miura M; Miyazato P; Kohara M; Matsuoka M
Blood; 2015 Aug; 126(9):1095-105. PubMed ID: 26063164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
